Is Class III lupus nephritis classified as focal proliferative or focal segmental disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Class III Lupus Nephritis is Focal Proliferative

Class III lupus nephritis is classified as focal proliferative glomerulonephritis, not focal segmental disease. The term "focal" refers to the involvement of less than 50% of glomeruli, while "proliferative" describes the endocapillary hypercellularity and inflammatory cell infiltration that characterizes this class 1.

Key Terminology Clarification

The confusion often arises from the term "segmental," which has a different meaning in lupus nephritis classification:

  • Focal = affects <50% of total glomeruli (distribution across the kidney)
  • Segmental = affects only part of an individual glomerulus (pattern within a single glomerulus)
  • Proliferative = endocapillary hypercellularity with leukocyte influx

Class III is defined as focal proliferative lupus nephritis because it involves active proliferative lesions (endocapillary hypercellularity, subendothelial immune deposits, leukocyte infiltration) affecting less than half of the glomeruli 1, 2.

Important Distinction from Focal Segmental Glomerulosclerosis (FSGS)

"Focal segmental" typically refers to focal segmental glomerulosclerosis (FSGS), which is an entirely different disease entity characterized by segmental sclerosis. This is not what Class III lupus nephritis represents. Class III is an immune complex-mediated proliferative disease with active inflammation, not a primary sclerosing process 1.

Evolution of Classification

The 2018 ISN/RPS revision actually eliminated the segmental (S) and global (G) subdivisions for Class IV due to poor interobserver agreement and weak clinical significance 3. However, the fundamental definition of Class III as focal proliferative disease remains unchanged. The distinction between segmental and global lesions within individual glomeruli is now retained only in microscopic descriptions rather than formal subclassification 3.

Clinical Implications

Understanding this terminology is critical because:

  • Class III (focal proliferative) has a better prognosis than Class IV (diffuse proliferative) when properly defined 2, 4
  • Treatment intensity may differ based on accurate classification 5
  • The "focal" designation specifically means <50% glomerular involvement, which has prognostic significance 1

Bottom line: Class III lupus nephritis is focal proliferative glomerulonephritis—"focal" describes the distribution (<50% of glomeruli), and "proliferative" describes the inflammatory nature of the lesions.

Related Questions

What is the recommended treatment regimen for lupus nephritis?
What is the recommended management of multiple skin boils (furunculosis) in an immunosuppressed patient with lupus nephritis?
Which of the following are correct classifications of lupus nephritis: diffuse proliferative, membranous, IgA nephropathy, membranoproliferative glomerulonephritis, or focal proliferative?
What is the recommended induction and maintenance treatment regimen for lupus nephritis in a pediatric patient?
Given normal CBC, kidney and liver function tests, and negative lupus antibodies, what is the likely diagnosis for my proximal muscle weakness, leg tremor‑like sensations at rest, intermittent muscle spasms, and back pain, and what laboratory workup and initial management should I pursue?
What is the appropriate past medical history entry for a patient who underwent knee surgery for medial collateral ligament (MCL) cartilage and meniscus repair on [DATE]?
Is focal proliferative glomerulonephritis the same as focal segmental glomerulonephritis?
What is the recommended management approach for obesity in Asian adults, including lifestyle interventions, pharmacotherapy, and bariatric surgery?
What is the clinical approach to managing new-onset dizziness?
How quickly does dexamethasone reduce free T4 and free T3 levels?
In a patient 10 days after pituitary surgery for a non‑functioning macroadenoma who remains polyuric and requires regular desmopressin (DDAVP), how should discharge fluid balance be monitored and what desmopressin dose should be prescribed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.